
|Articles|October 1, 1997
Oncology NEWS International
- Oncology NEWS International Vol 6 No 10
- Volume 6
- Issue 10
A Picture of Prostate Cancer in Europe
HAMBURG-The Federation of European Cancer Societies released information on prostate cancer in Europe at its biennial European Cancer Conference (ECCO 9).
Advertisement
HAMBURGThe Federation of European Cancer Societies released information on prostate cancer in Europe at its biennial European Cancer Conference (ECCO 9).
- In Europe, one man in 11 is diagnosed with prostate cancer, which accounts for 13% of all new cancer diagnoses and almost 9% of cancer deaths.
- The death rate tends to be highest in northern European countries and lowest in southern and eastern Europe.
- Death rates from prostate cancer have risen dramatically in recent years, probably because of the increasing number of elderly men in the population. In England and Wales, for example, there were 4,313 deaths attributed to prostate cancer in 1974, compared with 8,735 in 1992, a 103% increase in only 17 years.
Articles in this issue
almost 29 years ago
Toremifene, Tamoxifen Equivalent in Advanced Breast Canceralmost 29 years ago
Fluorescence ‘LIFE’ Images Spot Occult Lung Cancer Lesionsalmost 29 years ago
The Issue That Won’t Go Away: Screening Mammographyalmost 29 years ago
News in Brief...almost 29 years ago
Concurrent Better Than Sequential Chemo-RT in NSCLCalmost 29 years ago
Consumer Version of Merck & Co’s Famous Manual Is Availablealmost 29 years ago
A Talk With Dr. Richard Klausner, Head of the NCIalmost 29 years ago
Age Is a Factor in Survival of SqCC of the Head and Neckalmost 29 years ago
Symptom-Based Staging of Head & Neck CancerAdvertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Regulatory T-Cell Immunotherapy in Hematologic Malignancies
2
Purple Reign Vs Thriller: A Duel of The Top Frontline EGFR+ NSCLC Regimens
3
ASCO Breakthrough 2026 Wrap-Up: Precision Oncology, AI, and Biomarkers Define the Future of Cancer Care
4
Relapsed/Refractory Multiple Myeloma: CARTITUDE-4 and the Evolving Role of BCMA CAR T-Cell Therapy
5


















































































